Rein recently announced regulatory approval from the U.K.’s MHRA to initiate the Phase 2 RENEW trial of LTI-03. The trial will evaluate safety, tolerability, and changes in lung function in up to 120 ...

The U.S. Food and Drug Administration (FDA) approved ZURZUVAE in August 2023 and the Drug Enforcement Agency (DEA) scheduled it as a Class IV controlled substance in October 2023. In August 2025, ...

Postpartum depression is a leading cause of maternal mortality in Europe1-2, and is one of the most common medical conditions associated with pregnancy3-5; up to 20% of women experience postpartum dep ...

Among the difficulties of talking about denunciation is that there are so many words for it, along with sharply ...

Data support advancement of GS-6791 into clinical testing in patients with inflammatory diseases; first-in-human Phase 1 trial in healthy ...

Patent covers advanced signal processing for middle ear sensors, further advancing the Company’s position in leveraging the ear for fully implanted hearing devices White Bear Lake, ...

What I discovered when everything I owned had to fit into one small bag changed the way I see success, comfort, and home.

MindWalk Holdings Corp.™ ("MindWalk," "Company," "we" or "us") (Nasdaq: HYFT), a Bio-Native AI company, today announced a major advancement of its AI-designed GLP-1 therapeutics program. New insights ...

Our discussion of flat adverbs continues today as we, firstly, add more examples. I hope you remember what flat adverbs are: ...

Christian publishing can and does pursue many aims. But its most profound witness is to craft books that do more than merely ...

Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...

Discover why Duolingo, Inc.’s stock, now at a 50% discount with strong growth and AI integration, could offer 60% upside.